ARCHIVES

Klausner Reaffirms NCI’s “No. 1 Priority” Is Funding investigator-Initiated Research

This article is from The Cancer Letter archive.

Vol. 22 No. 35 | September 13, 1996

Download PDF Visit The Full Archive

Related Articles

Brachytherapy Prevents Endometrial Cancer Return

June 27, 2008

Drug Combination Can Block Proteins Preventing Cell Death In Acute Lymphoblastic Leukemia

September 27, 2013

Duke Deans Acknowledge Withholding Key Document From Outside Reviewers

January 14, 2011

Von Eschenbach Presents His “2015 Goal” As Logical Progression of Cancer Program (Interview)

May 16, 2003

FDA Names Director Of New Center For Tobacco Products

September 11, 2009

Hammer Agrees To Bush Request for FDA Probe

July 15, 1988